✦ LIBER ✦

An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies

✍ Scribed by Thomas C. Shea; Rebecca Bruner; Joseph M. Wiley; Jonathan S. Serody; Scott Sailer; Don A. Gabriel; Eileen Capel; Dominic T. Moore; Georgette Dent; Stuart Bentley; Mark E. Brecher

Book ID: 117727938
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 149 KB
Volume: 9
Category: Article
ISSN: 1083-8791
DOI: 10.1016/s1083-8791(03)00204-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-Myeloablative (NMA) Allogeneic Hemat

Non-Myeloablative (NMA) Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine and Total Body Irradiation (Bu/Flu/TBI) Conditioining: Results of a Phase II Trial

✍ Brammer, Jonathan E.; Stentz, Alex; Dibb, James; Frires, Rachel; Meyers, Gabriel 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Palifermin reduces severe oral mucositis

Palifermin reduces severe oral mucositis (OM), improves patient quality of life, and reduces health resource use in patients with hematologic malignancies receiving high-dose chemotherapy (HDCT) and total body irradiation (TBI) with autologous peripheral blood stem cell (PBSC) support: results from a phase III trial

✍ W. Bensinger; D. Weisdorf; T. Gentile; A. Cesano; D. Elhardt; C. Emmanouilides; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Long-term results of first-line sequenti

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group: Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schoffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group, Department of Hematology/Oncology, University of Halle, Halle, Germany.

✍ Jerome P Richie 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 18 KB